ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$8.45
Tradestie Score
33
Market Cap
$670.30M
P/E Ratio
33.5
Revenue Growth
10.1%
Analyst Upside
+64.8%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$15.88
|
$626.91M | - | 57 | Compare |
|
SVRA
Savara Inc.
|
$5.30
|
$611.84M | - | 50 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.29
|
$552.46M | - | 48 | Compare |
|
VSTM
Verastem, Inc.
|
$7.32
|
$541.60M | - | 46 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.91
|
$540.97M | - | 48 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.01
|
$529.35M | 13.0 | 49 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$110.26
|
$522.78M | - | 55 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.00
|
$512.39M | - | 48 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.24
|
$505.12M | 2.8 | 47 | Compare |
More ARVN Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry